Symptoms
Common signs and symptoms of Age-Related Macular Degeneration include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Age-Related Macular Degeneration.
The exact cause of age-related macular degeneration involves a complex interplay of aging, genetics, and environmental factors.
The exact cause of age-related macular degeneration involves a complex interplay of aging, genetics, and environmental factors. As we age, cellular waste products called drusen begin accumulating beneath the retina, much like sediment settling in a riverbed. In dry AMD, these deposits gradually interfere with the macula's ability to function properly, causing the light-sensitive cells to slowly deteriorate and die.
Wet AMD develops when the eye attempts to compensate for the damage by growing new blood vessels beneath the retina.
Wet AMD develops when the eye attempts to compensate for the damage by growing new blood vessels beneath the retina. Unfortunately, these new vessels are fragile and leaky, like poorly constructed plumbing. They allow blood and fluid to seep into the macula, causing rapid vision loss and scarring. This process, called choroidal neovascularization, can transform slowly progressing dry AMD into the more aggressive wet form.
While aging is the primary driver, AMD isn't simply an inevitable consequence of getting older.
While aging is the primary driver, AMD isn't simply an inevitable consequence of getting older. Your genes play a significant role, with certain genetic variants dramatically increasing risk. Environmental factors, particularly smoking and prolonged sunlight exposure, accelerate the damage. The condition represents a perfect storm where genetic predisposition meets cumulative environmental harm over decades.
Risk Factors
- Age over 50 years
- Family history of macular degeneration
- Smoking cigarettes or tobacco use
- Prolonged exposure to sunlight without eye protection
- High blood pressure or cardiovascular disease
- Obesity, particularly abdominal weight
- Light-colored eyes (blue or green)
- Being female
- Race (more common in Caucasians)
- Poor diet low in antioxidants and omega-3 fatty acids
Diagnosis
How healthcare professionals diagnose Age-Related Macular Degeneration:
- 1
Diagnosing AMD typically begins with a comprehensive eye examination by an ophthalmologist or optometrist.
Diagnosing AMD typically begins with a comprehensive eye examination by an ophthalmologist or optometrist. Your doctor will start by asking about your symptoms and family history, then test your visual acuity using an eye chart. They'll also perform a dilated eye exam, using special drops to widen your pupils so they can examine the retina and macula in detail.
- 2
Several specialized tests help confirm the diagnosis and determine the type of AMD.
Several specialized tests help confirm the diagnosis and determine the type of AMD. The Amsler grid test involves looking at a chart with straight lines to detect any wavy or missing areas in your central vision. Optical coherence tomography (OCT) creates detailed cross-sectional images of the retina, allowing doctors to see fluid accumulation or structural changes. For suspected wet AMD, fluorescein angiography involves injecting a dye into your arm and photographing how it flows through the blood vessels in your eye.
- 3
Doctors must distinguish AMD from other conditions that can cause similar symptoms.
Doctors must distinguish AMD from other conditions that can cause similar symptoms. These include diabetic retinopathy, which affects people with diabetes, and central serous retinopathy, which can cause fluid accumulation under the retina in younger patients. Macular holes, retinal detachment, and even cataracts can sometimes mimic AMD symptoms, making thorough examination essential for accurate diagnosis.
Complications
- The primary complication of AMD is progressive vision loss that can significantly impact daily activities.
- In dry AMD, this typically occurs gradually over years, allowing people time to adapt and learn new strategies.
- However, wet AMD can cause rapid, severe vision loss within days or weeks if left untreated.
- Early detection and prompt treatment are essential to prevent permanent damage.
- While AMD rarely causes complete blindness, advanced cases can result in legal blindness, defined as vision worse than 20/200 in the better eye.
- Most people retain their peripheral vision, but the loss of central vision can make reading, driving, cooking, and recognizing faces extremely challenging.
- Depression and social isolation sometimes develop as people struggle to maintain their independence and previously enjoyed activities.
- However, with proper support, low-vision aids, and rehabilitation services, many people successfully adapt to vision changes and continue living fulfilling lives.
Prevention
- Wearing sunglasses with UV protection whenever outdoors
- Maintaining a healthy weight through regular exercise
- Managing blood pressure and cardiovascular health
- Having regular comprehensive eye exams, especially after age 50
- Using the Amsler grid at home to monitor for vision changes
Treatment for AMD depends primarily on which type you have.
Treatment for AMD depends primarily on which type you have. For dry AMD, the focus centers on slowing progression through lifestyle changes and nutritional supplements. The AREDS2 formula, containing vitamins C and E, zinc, copper, lutein, and zeaxanthin, has shown significant benefit in reducing the risk of progression to advanced AMD. These supplements work best for people with intermediate dry AMD or advanced AMD in one eye.
Wet AMD requires more aggressive intervention to prevent rapid vision loss.
Wet AMD requires more aggressive intervention to prevent rapid vision loss. Anti-VEGF injections represent the gold standard treatment, with medications like ranibizumab (Lucentis), aflibercept (Eylea), and bevacizumab (Avastin) delivered directly into the eye. These drugs block the growth of abnormal blood vessels and reduce fluid leakage. Most patients need monthly injections initially, though some can eventually extend the interval between treatments.
For cases where anti-VEGF therapy isn't sufficient, doctors might recommend photodynamic therapy, which uses a light-activated drug to destroy abnormal blood vessels.
For cases where anti-VEGF therapy isn't sufficient, doctors might recommend photodynamic therapy, which uses a light-activated drug to destroy abnormal blood vessels. Laser photocoagulation, while less commonly used now, can seal leaking blood vessels in specific situations. Some patients benefit from combination therapies that use multiple approaches simultaneously.
Exciting developments on the horizon include longer-acting anti-VEGF medications that require fewer injections, gene therapy approaches that could address the underlying genetic factors, and stem cell treatments being studied in clinical trials.
Exciting developments on the horizon include longer-acting anti-VEGF medications that require fewer injections, gene therapy approaches that could address the underlying genetic factors, and stem cell treatments being studied in clinical trials. Researchers are also investigating complement inhibitors, which target the immune system's role in AMD development, potentially offering new options for both dry and wet forms of the disease.
Living With Age-Related Macular Degeneration
Living well with AMD starts with building a strong support team that includes your eye doctor, family members, and potentially a low-vision specialist. Regular monitoring is essential - people with dry AMD should check their vision daily using an Amsler grid and report any changes immediately. Those with wet AMD need consistent follow-up appointments and treatment to maintain vision stability.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Feb 27, 2026v1.0.1
- Fixed narrative story opening in excerpt
- Excerpt no longer starts with a named-character or scenario opening
Feb 26, 2026v1.1.0
- Updated broken source links
- Replaced or removed 404 dead links
Jan 21, 2026v1.0.0
- Published page overview and treatments by DiseaseDirectory